Drug induced steatohepatitis: an uncommon culprit of a common disease

L Rabinowich, O Shibolet - BioMed research international, 2015 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed
countries. Its frequency is increasing in the general population mostly due to the widespread …

Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature

AER Bravo, J Drewe, RG Schlienger… - Critical care …, 2005 - journals.lww.com
Objective: Atrial fibrillation is the most common arrhythmia after cardiac surgery. Amiodarone
can effectively prevent and control postoperative atrial and ventricular fibrillation. Acute …

[图书][B] Drug-induced liver disease

N Kaplowitz, LD DeLeve - 2007 - taylorfrancis.com
Featuring more than 4100 references, Drug-Induced Liver Disease is an invaluable
reference for gastroenterologists, hepatologists, family physicians, internists, pathologists …

Amiodarone hepatotoxicity

M Babatin, SS Lee, PT Pollak - Current vascular pharmacology, 2008 - ingentaconnect.com
Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with …

Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration

X Ren, X Mao, L Si, L Cao, H Xiong, J Qiu… - European journal of …, 2008 - Elsevier
Excipients are largely used as inert vehicles in formulation. Recent studies indicated that
some excipients could affect drug transport and disposition. But the effects of most excipients …

Mediation of in vitro cytochrome P450 activity by common pharmaceutical excipients

P Martin, M Giardiello, TO McDonald… - Molecular …, 2013 - ACS Publications
Polymers and surfactants are commonly used as excipients in oral formulations and are
generally considered to be inert. However, relatively few studies have assessed their …

Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use

K Raja, SN Thung, MI Fiel… - Seminars in Liver Disease, 2009 - thieme-connect.com
Nonalcoholic steatosis/steatohepatitis is the most common cause for abnormal liver
chemistries. Apart from metabolic syndrome, drugs may also lead to development of …

Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature

M Nasser, TR Larsen, B Waanbah, I Sidiqi… - Drug, healthcare and …, 2013 - Taylor & Francis
Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …

[HTML][HTML] Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy

M Lahbabi, N Aqodad, A Ibrahimi… - World Journal of …, 2012 - ncbi.nlm.nih.gov
Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat cardiac rhythm
abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone and …

[HTML][HTML] N-acetylcysteine treats intravenous amiodarone induced liver injury

ML Mudalel, KP Dave, JP Hummel… - World Journal of …, 2015 - ncbi.nlm.nih.gov
We report a case of intravenous (IV) amiodarone drug induced liver injury (DILI). The patient
received IV N-acetylcysteine (NAC) which resulted in a rapid improvement in liver enzymes …